A detailed history of Balyasny Asset Management LLC transactions in Biogen Inc. stock. As of the latest transaction made, Balyasny Asset Management LLC holds 394,887 shares of BIIB stock, worth $68.6 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares
394,887
Holding current value
$68.6 Million
% of portfolio
0.17%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$190.52 - $236.72 $75.2 Million - $93.5 Million
394,887 New
394,887 $91.5 Million
Q4 2023

Feb 14, 2024

BUY
$222.59 - $267.94 $19.3 Million - $23.3 Million
86,891 Added 37.71%
317,302 $82.1 Million
Q3 2023

Nov 14, 2023

BUY
$253.3 - $285.89 $43.2 Million - $48.7 Million
170,423 Added 284.1%
230,411 $59.2 Million
Q2 2023

Aug 14, 2023

SELL
$275.25 - $318.06 $49.4 Million - $57.1 Million
-179,407 Reduced 74.94%
59,988 $17.1 Million
Q1 2023

May 15, 2023

BUY
$256.56 - $292.34 $48.2 Million - $55 Million
188,012 Added 365.9%
239,395 $66.6 Million
Q4 2022

Feb 14, 2023

SELL
$252.44 - $306.72 $31.5 Million - $38.3 Million
-124,782 Reduced 70.83%
51,383 $14.2 Million
Q3 2022

Nov 14, 2022

BUY
$194.69 - $268.46 $29.8 Million - $41 Million
152,859 Added 655.88%
176,165 $47 Million
Q2 2022

Aug 15, 2022

SELL
$187.54 - $223.02 $27.2 Million - $32.3 Million
-144,870 Reduced 86.14%
23,306 $4.75 Million
Q1 2022

May 16, 2022

BUY
$193.77 - $244.14 $16.8 Million - $21.2 Million
86,932 Added 107.0%
168,176 $35.4 Million
Q4 2021

Feb 14, 2022

BUY
$223.92 - $287.77 $7.77 Million - $9.99 Million
34,709 Added 74.59%
81,244 $19.5 Million
Q3 2021

Nov 15, 2021

SELL
$282.99 - $369.05 $26 Million - $33.9 Million
-91,744 Reduced 66.35%
46,535 $13.2 Million
Q2 2021

Aug 16, 2021

BUY
$259.0 - $414.71 $12.6 Million - $20.2 Million
48,659 Added 54.29%
138,279 $47.9 Million
Q1 2021

May 17, 2021

BUY
$242.95 - $284.63 $13.2 Million - $15.5 Million
54,485 Added 155.07%
89,620 $25.1 Million
Q4 2020

Feb 16, 2021

SELL
$236.26 - $355.63 $27.9 Million - $42 Million
-118,123 Reduced 77.07%
35,135 $8.6 Million
Q3 2020

Nov 16, 2020

BUY
$264.77 - $305.71 $6.25 Million - $7.21 Million
23,589 Added 18.19%
153,258 $43.5 Million
Q4 2019

Feb 14, 2020

BUY
$220.06 - $304.07 $25.5 Million - $35.2 Million
115,873 Added 839.9%
129,669 $38.5 Million
Q3 2019

Nov 14, 2019

SELL
$217.44 - $243.88 $23.2 Million - $26 Million
-106,661 Reduced 88.55%
13,796 $3.21 Million
Q2 2019

Aug 14, 2019

BUY
$219.29 - $241.72 $21.3 Million - $23.5 Million
97,034 Added 414.27%
120,457 $28.2 Million
Q1 2019

May 15, 2019

SELL
$216.71 - $338.96 $18 Million - $28.2 Million
-83,143 Reduced 78.02%
23,423 $5.54 Million
Q4 2018

Feb 14, 2019

BUY
$278.5 - $352.75 $27.9 Million - $35.3 Million
100,039 Added 1532.69%
106,566 $32.1 Million
Q3 2018

Nov 14, 2018

SELL
$293.51 - $383.83 $11.5 Million - $15 Million
-39,178 Reduced 85.72%
6,527 $2.31 Million
Q2 2018

Aug 14, 2018

SELL
$257.52 - $306.91 $102 Million - $121 Million
-394,455 Reduced 89.62%
45,705 $13.3 Million
Q1 2018

May 15, 2018

SELL
$260.13 - $367.91 $28 Million - $39.5 Million
-107,449 Reduced 19.62%
440,160 $121 Million
Q4 2017

Feb 14, 2018

BUY
$307.64 - $344.58 $118 Million - $133 Million
385,130 Added 237.03%
547,609 $174 Million
Q3 2017

Nov 14, 2017

BUY
$281.15 - $329.69 $45.7 Million - $53.6 Million
162,479
162,479 $50.9 Million

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $25B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Balyasny Asset Management LLC Portfolio

Follow Balyasny Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Balyasny Asset Management LLC with notifications on news.